Research funder · United States
Alzheimer's Association
A non-profit American health organization which focuses Alzheimer's disease
- Grants since 2016
- 1 779
- Awarded, last 5 years (where amounts are published)
- —
- Funded works, last 5 years
- 7 372
- Funded works, all time
- 14.6k
Grants
2017 · research · AARG
Role of N-terminal Residues in Membrane-Mediated Aß Assembly and Toxicity
Deguo Du · Florida Atlantic University
2017 · research · AARG
Molecular mechanisms of cognitive decline in Alzheimer’s disease
Antonella Caccamo · Arizona State University Foundation For A New American University
2017 · research · AARG
Racial and Ethnic Disparities in ADRD Diagnosis, Treatment and Costs
Pei-Jung Lin · Tufts Medical Center
2017 · research · ZEN
Dissecting the role of human astroglia in Alzheimer’s disease
Bart De Strooper · Vibvzw
2017 · research · AARF
A genomic screen to identify endogenous regulators of APP/BACE interaction
Jichao Sun · University of Wisconsin System
2017 · research · AARG
In vivo entorhinal-hippocampal synchronization in APP knock-in mice
Kei Igarashi · University of California, Irvine
2017 · research · AARG
Neuroinflammatory susceptibility to vascular disease as a dementia driver
Walter Swardfager · Sunnybrook Research Institute
2017 · research · AARF
The impact of motherhood and APOE genotype on the aging brain
Paula Duarte-Guterman · University of British Columbia
2017 · research · AARG
Functional and Cognitive Health Assessment of Older Adults with Dementia
Nirmalya Roy · University of Maryland, Baltimore County
2017 · research · AARF
Study of the Psychosocial Effects of Preclinical Alzheimer’s Disease
Shana Stites · The Trustees Of The University Of Pennsylvania
2017 · research · SAGA
Estradiol-APOE interactions in a mouse model of AD
Karyn Frick · University of Wisconsin–Milwaukee
2017 · research · AARF
Drug development of a novel PDE5 inhibitor for Alzheimer’s disease
Jole Fiorito · Columbia University Irving Medical Center
2017 · research · AARG
Brain blood flow in middle-aged adults at low and high risk of AD
Jill Barnes · University of Wisconsin System
2017 · research · AARF-D
Attenuating Aß-driven hyperexcitability and tau spread
Gustavo Rodriguez · Columbia University Irving Medical Center
2017 · research · AARF
Effects of psychotropic medications in a mouse model of tauopathy.
Aurelie Joly-Amado · University of South Florida
2017 · research · AARF-D
Monitoring the Onset and Evolution of Neuronal Dysfunctions
Gemma Navarro · Fundacio Bosch I Gimpera-university Of Barcelona
2017 · research · AARG
Sensor and Simulation-based Fall Injury Mitigation for Senior Citizens
Michel Audette · Old Dominion University
2017 · research · AARF
The Consequences of Activity-Induced DNA Breaks in Alzheimer's Disease
Dylan Reid · Salk Institute for Biological Studies
2017 · research · AARG
Discovery of novel mechanisms by which sleep modulates Aß toxicity
Ravi Allada · Northwestern University
2017 · research · AARG
Longitudinal Cognitive and Biomarker Trajectories of MCI Subtypes
Emily Edmonds · University Of California
2017 · research · PTC
A Phase I single ascending dose safety and pharmacokinetic study of NTRX-07
Joseph Foss · Neurotherapia, Inc.
2017 · research · AARG
Protective vascular factors in mild cognitive impairment
Daniel Nation · Usc/university Of Southern California
2017 · research · AARG
Role of polyubiquitination in Alzheimer’s disease
Mariapina D'Onofrio · University of Verona
2017 · research · AARF
Sleep, cognition, and inflammation following natural or surgical menopause
Nicole Gervais · Governing Council Of The University Of Toronto
2017 · research · AARF
Axonal Transcription Factor Complexes in Alzheimer’s Disease
Cláudio Gouveia Roque · Columbia University Irving Medical Center
2017 · research · ZEN
RAGE, Diaph1, Microglia and Alzheimer’s Disease
Ann-Marie Schmidt · New York University
2017 · research · AARG
Generation of a blood brain barrier from Alzheimer's Disease patient iPSCs
Matt Inlay · University of California, Irvine
2017 · research · AARF
Roles of DCTN6 in tubular ER clustering and DNs formation in AD
Md. Golam Sharoar · Cleveland Clinic
2017 · research · AARF
Identifying neurons vulnerable to tau pathology in early AD
Hongjun Fu · The Trustees Of Columbia University In The City Of New York
2017 · research · AARF
Sex differences in exercise efficacy: Possible role of BDNF and stress axis
Cindy Barha · University of British Columbia
2017 · research · AARG
Group Therapy For Dementia Caregivers At Risk For Complicated Grief
Katherine Supiano · University of Utah
2017 · research · AARG
Neural Mechanisms of Spatial Disorientation in Alzheimer’s disease
Benjamin Clark · University of New Mexico
2017 · research · AARG
Targeting Adult Neurogenesis for Alzheimer’s Disease Therapy
Se Hoon Choi · Massachusetts General Hospital
2017 · research · SAGA
Gender difference in Human and Primate Serotonin Network
P. Hemachandra Reddy · Texas Tech University Health Sciences Center
2017 · research · AACSF-D
Strategies to prevent cognitive decline in non-demented subjects
Tanja Stojkovic · University Of Belgrade, Medical Faculty, Neurology Clinic
2017 · research · AARG
Role of Sumoylation in the aggregation and toxicity of TAU
Luana Fioriti · Istituto Di Ricerche Farmacologiche Mario Negri (pharmacological Research Institute Mario Negri)
2017 · research · AARG
Examining the trajectory of Subjective Cognitive Decline in preclinical AD
Rebecca Amariglio · Brigham and Women's Hospital
2017 · research · AARG
Developing advanced blood-brain barrier permeability imaging for early AD
Yulin Ge · New York University
2017 · research · AARG
Pathomechanisms of TDP-43 in Alzheimer’s disease
Xinglong Wang · Case Western Reserve University
2017 · research · AACF
Transcriptomic Changes of Astrocytes in Alzheimer's Disease
Alberto Serrano-Pozo · Massachusetts General Hospital
